Compare Personalis Inc. Common Stock (PSNL) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Personalis Inc. Common Stock vs Thomson Reuters Corp — how do they compare? Personalis Inc. Common Stock trades at $16.14 (market cap $1.70B), while Thomson Reuters Corp trades at $106.46 (market cap $45.71B). The key difference: Thomson Reuters Corp is far larger — about 26.9× Personalis Inc. Common Stock's market cap, and Thomson Reuters Corp pays a 2.49% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Thomson Reuters Corp for 63 Days on average.
| PSNL | TRI | |
|---|---|---|
Market Cap | $1.70B | $45.71B |
Volume | 3,262,398 | 1,278,997 |
Sector | Health | Industrials |
52-Week High | $18.38 | $163.45 |
52-Week Low | $5.04 | $76.55 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $1.52B | $48.32B |
Dividend Yield | — | 2.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Thomson Reuters (TRI) trades at $105.14, up 0.85% on the day, with strong technical momentum and bullish analyst sentiment. The company demonstrates solid fundamentals with 10% organic growth in core businesses and a 21.22% net income margin. Recent strategic moves include divesting its printing unit to focus on technology offerings and launching a proprietary AI model, positioning for future growth. Cash flow trends show operational strength despite recent negative net cash flow due to strategic investments.
TRI presents a compelling investment case with analyst consensus target of $128.60 (22% upside), strong recurring revenue model, and AI expansion potential. Key risks include execution challenges in technology transition, cybersecurity vulnerabilities highlighted by recent incidents, and competitive pressures in legal tech. The stock's current valuation at 27.77 P/E requires continued earnings growth to justify premium pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
